Copaxone and Qvar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Qvar (beclomethasone dipropionate). Common drug interactions include tinnitus among females and convulsion among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Qvar. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Qvar?

Qvar has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 17,355 Qvar users. Check the latest studies of Qvar.

On Jul, 19, 2026

28 people who take Copaxone and Qvar together, and have interactions are studied.

What are the common drug interactions of Copaxone and Qvar, by gender? *:

female:

Tinnitus (a ringing in the ears)
Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
Uterine cancer
Vomiting
Wheezing (a high-pitched whistling sound made while you breath)
White blood cell count increased
Fatigue (feeling of tiredness)
Memory impairment
Decreased appetite
Fall

male:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Road traffic accident
Therapeutic response unexpected
Balance disorder
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Fall
Flushing (the warm, red condition of human skin)
Pruritus (severe itching of the skin)
Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Copaxone and Qvar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Memory impairment
Personality change
Visual impairment
Wrist fracture
Constipation
Diarrhoea
Dizziness
Injection site reaction
Joint injury
Fatigue (feeling of tiredness)

40-49:

Balance disorder
Injection site reaction
Anxiety
Burning sensation
Contusion (a type of hematoma of tissue in which capillaries)
Depression
Diplopia (double vision)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fatigue (feeling of tiredness)
Injection site bruising

50-59:

Pain
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Abdominal pain
Acute sinusitis
Alopecia (absence of hair from areas of the body)
Anger
Asthenia (weakness)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Contusion (a type of hematoma of tissue in which capillaries)
Cough

60+:

Memory impairment
Muscle spasms (muscle contraction)
Anxiety
Asthenia (weakness)
Balance disorder
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Drug ineffective
Dysgeusia (disorder of the sense of taste)
Dysphonia (speech disorder attributable to a disorder of phonation)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 3 people, 10.71%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 7.14%
Gait Disturbance: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Qvar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously